Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lomustine and Intermediate Dose Cytarabine in Older Patients With Acute Myeloid Leukaemia
NCT00480064Phase 3Completed
- Sponsor
- French Innovative Leukemia Organisation
- Start
- Jul 1995
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of lomustine, cytarabine in acute myeloid leukemia (AML), sponsored by French Innovative Leukemia Organisation. Started Jul 1995; status: completed.
02
Drugs
lomustinecytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00480064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00480064.